Please check your internet connection and try again.
# Sinex (Oxymetazoline)
## Overview
Oxymetazoline is a direct-acting sympathomimetic amine that acts as an alpha-adrenergic agonist. It causes vasoconstriction of the arterioles in the nasal mucosa, resulting in decreased swollen tissue and increased nasal patency.
## Primary Indications
* Temporary relief of nasal congestion caused by the common cold, hay fever, or upper respiratory allergies.
* Sinus congestion and pressure.
## Adult Dosing
* **Intranasal (0.05% solution):** 2–3 sprays in each nostril every 10–12 hours.
* **Maximum Dose:** Do not exceed 2 doses in any 24-hour period.
* **Maximum Duration:** Limit use to **3 consecutive days** to prevent rebound congestion (*rhinitis medicamentosa*).
## Pediatric Dosing
* **Children 6 to 12 years:** 2–3 sprays of the 0.025% (pediatric strength) solution in each nostril every 10–12 hours.
* **Maximum Dose:** Do not exceed 2 doses in any 24-hour period.
* **Children < 6 years:** Not recommended unless under direct supervision and specific recommendation of a pediatrician.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No formal dosage adjustments provided by the manufacturer; however, patients with severe cardiovascular disease should exercise extreme caution.
## Contraindications
* Hypersensitivity to oxymetazoline or any components of the formulation.
* Patients currently taking or having taken a monoamine oxidase inhibitor (MAOI) within the last 14 days (risk of hypertensive crisis).
## Adverse Effects
* **Common:** Burning at the site of administration, stinging, sneezing, or increased nasal discharge.
* **Serious:** Rebound nasal congestion (if used >3 days), systemic sympathomimetic effects (tachycardia, hypertension, palpitations, tremors, insomnia, or anxiety).
## Key Drug Interactions
* **MAOIs:** Risk of severe hypertensive crisis.
* **Tricyclic Antidepressants (TCAs):** May potentiate the pressor effects of oxymetazoline.
* **Beta-blockers/Antihypertensives:** May antagonize the effects of blood pressure lowering medications.
## Monitoring
* Monitor for duration of use (ensure use does not exceed 3 days).
* Assess for systemic side effects such as elevated blood pressure or heart rate, particularly in patients with pre-existing cardiovascular conditions.
## Clinical Pearls
* **Rebound Congestion:** Chronic overuse leads to *rhinitis medicamentosa*, a cycle where the nasal mucosa becomes dependent on the medication to remain patent; treatment involves gradual withdrawal or transition to intranasal corticosteroids.
* **Administration:** Instruct patients to sniff deeply while spraying to ensure proper distribution and to avoid sharing containers to prevent cross-contamination.
* **Formulation:** Ensure the correct concentration (0.025% vs 0.05%) is used, especially in pediatric patients.
***
**Educational Disclaimer:** This information is for educational purposes and does not substitute professional medical advice. Always consult current institutional protocols, prescribing leaflets, or clinical pharmacists to verify dosing and safety information before administration.
